Mahmoudvand Hossein, Sharififar Fariba, Sharifi Iraj, Ezatpour Behrouz, Fasihi Harandi Majid, Makki Mahsa Sadat, Zia-Ali Naser, Jahanbakhsh Sareh
Dept. of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman, Iran ; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Dept. of Pharmacognosy, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Iran J Parasitol. 2014 Mar;9(1):28-36.
Leishmaniasis has been identified as a major public health problem in tropical and sub-tropical countries. The present study was aimed to investigate antileishmanial effects of various extracts of Berberis vulgaris also its active compoenent, berberine against Leishmania tropica and L. infantum species on in vitro experiments.
In this study in vitro antileishmanial activity of various extracts of B. vulgaris also its active compoenent, berberine against promastigote and amastigote stages of L. tropica and L. infantum was evaluated, using MTT assay and in a macrophage model, respectively. Furthermore, infectivity rate and cytotoxicity effects of B. vulgaris and berberine in murine macrophage cells were investigated.
The findings of optical density (OD) and IC50 indicated that B. vulgaris particulary berberine significantly (P<0.05) inhibited the growth rate of promastigote stage of L.tropica and L.infantum in comparison to meglumine antimoniate (MA). In addition, B. vulgaris and berberine significantly (P<0.05) decreased the mean number of amastigotes in each macrophage as compared with positive control. In the evaluation of cytotoxicity effects, it could be observed that berberine as compared with B. vulgaris exhibited more cytotoxicity against murine macrophages. Results also showed that when parasites were pre-incubated with B. vulgaris their ability to infect murine macrophages was significantly decreased.
B.vulgaris particularly berberine exhibited potent in vitro leishmanicidal effects against L. tropica and L.infantum. Further works are required to evaluate the antileishmanial effects of B.vulgaris on Leishmania species using clinical settings.
利什曼病已被认定为热带和亚热带国家的一个主要公共卫生问题。本研究旨在通过体外实验,探究小檗的各种提取物及其活性成分黄连素对热带利什曼原虫和婴儿利什曼原虫的抗利什曼作用。
在本研究中,分别采用MTT法和巨噬细胞模型,评估了小檗的各种提取物及其活性成分黄连素对热带利什曼原虫和婴儿利什曼原虫前鞭毛体和无鞭毛体阶段的体外抗利什曼活性。此外,还研究了小檗和黄连素在小鼠巨噬细胞中的感染率和细胞毒性作用。
光密度(OD)和IC50的结果表明,与葡甲胺锑酸盐(MA)相比,小檗尤其是黄连素显著(P<0.05)抑制了热带利什曼原虫和婴儿利什曼原虫前鞭毛体阶段的生长速率。此外,与阳性对照相比,小檗和黄连素显著(P<0.05)降低了每个巨噬细胞中无鞭毛体的平均数量。在细胞毒性作用评估中,可以观察到黄连素比小檗对小鼠巨噬细胞表现出更高的细胞毒性。结果还表明,当寄生虫与小檗预孵育时,它们感染小鼠巨噬细胞的能力显著降低。
小檗尤其是黄连素对热带利什曼原虫和婴儿利什曼原虫表现出强大的体外杀利什曼作用。需要进一步开展工作,以在临床环境中评估小檗对利什曼原虫物种的抗利什曼作用。